Replies to post #391325 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Brilacidin is being tested by NIH labs as a broad spectrum anti-viral and reportedly seeing good results. Long term market wise covid-19 could end up being small potatoes. Yep some 20 viruses and counting.

[loanranger]

"I'm starting to believe that if they would had given the company the choice to try mild to moderate first, they would had taken that"

I guess you didn't like my carefully considered response. This one is simpler and more direct:
The FDA provided feedback based on the Company's submission. The decision to run the test as it was run was made by the Company.

Would you rather they not run the test at all? Did the CEO run a test that he shouldn't have run? How many patients with mild symptoms would have gone back and forth to the infusion suite for 5 days in a row?
There were many mild-to-moderate tests run.....using drugs in pill form or an inhaler.

Quit blaming the bogeyman for the CEO's choices....he made them himself.

[JPsooner]

I think you're right.

Hopefully, things are changing for the better at the FDA and others. It does seem like B is getting more of a chance now.

[frenchbroad]

For the test against the new virus Brilacidin required people with a needle direct in a vein to administer the drug. It is how it was tested with success for MRSA. People with only mild virus sickness do not have a needle in a vein. People with moderate virus sickness maybe have a needle or maybe not.

There was no USA FDA conspiracy against Brilacidin and Ipix.

I did hope the anti-inflammation action of Brilacidin could help those who were super sick.

The anti-viral story with Brilacidin is in only the first chapter.